Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

U.K. approval for Edronax

April 21, 1997

Imitrex Nasal Spray introduced in Canada

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

Biovail's Tiazac approved and introduced in Canada

April 17, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Generic minoxidil receives FDA approval

April 16, 1997

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Nasacort now available for the treatment of allergic rhinitis

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...